Centers

Therapeutic Accelerator Program (TAP)

test

TEST

Partnerships

Events

Jobs

Brigham & Woman's Hospital and Sanofi to Partner in Type 1 Diabetes Space

Sanofi and Brigham & Woman's Hospital an affiliate of Harvard University have entered into a joint collaboration to develop new drugs based on novel immunomodulatory approach to treat Type 1 Diabetes. Scientists from both groups will be...

Sanofi and Weill Cornell Medical College to Discover New Drus to Treat Tuberculosis

Sanofi has entered into a new collaboration with Dr.Carl Nathan's laboratory at Weill Cornell Medical College to screen existing compounds and develop new compounds to shorten the course of treatment of tuberculosis and increase effectiveness of...

Johns Hopkins BSi Licenses GCPII Assets from Eisai

Johns Hopkins Brain Science Institute ("BSi") has taken a non-exclusive license from Eisai to develop new compounds related to Glutamate Carboxypeptidase II (GCP-II) technology. The new compounds developed under this license will be targeted...

No EVENTS for listing

No Job Posts